English | Español

Astrazeneca Pharmaceuticals Lp
+ Regulatory
Mark Iandolo | Nov 22, 2017

AstraZeneca's benralizumab receives positive opinion from European Medicines Agency's CHMP
+ Technology/Innovation
Mark Iandolo | Nov 22, 2017

AstraZeneca, MedImmune deliver 28 presentations at AHA Scientific Sessions
+ Technology/Innovation
Nicholas Gueguen | Aug 1, 2017

MedImmune, Sanofi Pasteur to create and market respiratory tract illness prevention drug
+ Regulatory
Nicholas Gueguen | Jul 23, 2017

FDA approves AstraZeneca's Tagrisso for treating certain forms of lung cancer
+ Technology/Innovation
Robert Hadley | Jul 5, 2017

AstraZeneca’s Faslodex to treat breast cancer a step closer to approval in Europe
+ Regulatory
Erianne Leatherman | Jun 29, 2017

AstraZeneca’s Imfinzi gains FDA accelerated approval for bladder cancer patients
+ Technology/Innovation
Ruth de Jauregui | Jun 7, 2017

AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza
+ Regulatory
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes